- To estimate the cost of follow-up among colorectal cancer patients treated with curative intent based on the broad spectrum of surveillance strategies suggested in the literature.
- Economic analysis of the costs associated with 11 separate surveillance strategies.
Charge data were obtained from the Part B Medicare Annual Data file and the Hospital Outpatient Bill file.
- Ambulatory care.
- Medicare-allowed charges and an actual-charge proxy for 5 years of follow-up after treatment for colorectal cancer patients on a nationwide basis.
- Medicare-allowed charges varied widely for the 5 years of posttreatment follow-up from a low of $561 to a high of $16492.
When Medicare-allowed charges were converted to a proxy for actual charges using a conversion ratio of 1.62, the range was $910 to $26 717, a 28-fold difference in charges.
- Charges vary extensively across follow-up strategies, with no indication that higher-cost strategies increase survival or quality of life.
Mots-clés Pascal : Tumeur, Rectum, Côlon, Economie santé, Surveillance, Maladie, Evolution, Homme, Appareil digestif pathologie, Intestin pathologie, Tumeur maligne
Mots-clés Pascal anglais : Tumor, Rectum, Colon, Health economy, Surveillance, Disease, Evolution, Human, Digestive diseases, Intestinal disease, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0412242
Code Inist : 002B13B01. Création : 01/03/1996.